Forsta AP Fonden lessened its holdings in shares of Colgate-Palmolive (NYSE:CL) by 38.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 9,266 shares of the company’s stock after selling 5,900 shares during the period. Forsta AP Fonden’s holdings in Colgate-Palmolive were worth $620,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Palisade Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 0.6% in the 3rd quarter. Palisade Asset Management LLC now owns 141,610 shares of the company’s stock worth $9,481,000 after buying an additional 795 shares in the last quarter. DF Dent & Co. Inc. raised its holdings in shares of Colgate-Palmolive by 7.1% in the 2nd quarter. DF Dent & Co. Inc. now owns 12,125 shares of the company’s stock worth $786,000 after buying an additional 800 shares in the last quarter. Hugh Johnson Advisors LLC raised its holdings in shares of Colgate-Palmolive by 8.0% in the 2nd quarter. Hugh Johnson Advisors LLC now owns 10,861 shares of the company’s stock worth $704,000 after buying an additional 801 shares in the last quarter. West Oak Capital LLC raised its holdings in shares of Colgate-Palmolive by 3.2% in the 3rd quarter. West Oak Capital LLC now owns 27,049 shares of the company’s stock worth $1,811,000 after buying an additional 830 shares in the last quarter. Finally, Pendal Group Ltd raised its holdings in shares of Colgate-Palmolive by 2.3% in the 3rd quarter. Pendal Group Ltd now owns 37,455 shares of the company’s stock worth $2,508,000 after buying an additional 854 shares in the last quarter. 75.22% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have recently issued reports on CL. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating for the company in a report on Monday, July 23rd. Wells Fargo & Co dropped their target price on Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating for the company in a report on Wednesday, October 17th. Argus dropped their target price on Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating for the company in a report on Tuesday, October 30th. ValuEngine raised Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Tuesday, July 31st. Finally, Morgan Stanley dropped their target price on Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating for the company in a report on Tuesday, October 30th. Four analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $68.06.

NYSE CL opened at $63.24 on Friday. The company has a market cap of $54.18 billion, a P/E ratio of 20.96, a price-to-earnings-growth ratio of 3.07 and a beta of 0.75. Colgate-Palmolive has a one year low of $57.41 and a one year high of $77.91. The company has a debt-to-equity ratio of 64.85, a quick ratio of 0.77 and a current ratio of 1.11.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 26th. The company reported $0.72 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.72. The business had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. Colgate-Palmolive’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.73 EPS. Analysts forecast that Colgate-Palmolive will post 2.96 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 15th. Investors of record on Friday, October 19th were given a dividend of $0.42 per share. The ex-dividend date of this dividend was Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a yield of 2.66%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.

In related news, CFO Henning I. Jakobsen sold 1,015 shares of the stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $68,055.75. Following the sale, the chief financial officer now directly owns 36,193 shares in the company, valued at approximately $2,426,740.65. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Philip G. Shotts sold 462 shares of the stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total value of $30,977.10. Following the sale, the vice president now owns 41,250 shares in the company, valued at $2,765,812.50. The disclosure for this sale can be found here. 1.02% of the stock is owned by corporate insiders.

WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2018/11/17/colgate-palmolive-cl-shares-sold-by-forsta-ap-fonden.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

See Also: Cost of Equity For A Business, Investors

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.